Fidelity Disruptive Medicine ETF (FMED) Holdings $24.60 -0.07 (-0.28%) (As of 07/26/2024 ET) Add Compare Share Share HoldingsStock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsStock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrends Top 50 FMED HoldingsRankCompanyCurrent PriceWeightShares Held1BSXBoston Scientific$74.95+0.9%6.44%43,7792ALNYAlnylam Pharmaceuticals$234.84-1.3%5.42%10,8613UNHUnitedHealth Group$569.80+1.8%4.14%4,2884ISRGIntuitive Surgical$441.30+1.0%3.86%4,5505PODDInsulet$193.30+1.3%3.56%9,1346DHRDanaher$274.13+1.5%3.54%7,509 Get the Latest News and Ratings for FMED and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Fidelity Disruptive Medicine ETF and its competitors with MarketBeat's FREE daily newsletter. 7CNCCentene$73.10+8.5%3.12%24,2618REGNRegeneron Pharmaceuticals$1,078.63+1.4%2.78%1,3439LLYEli Lilly and Company$805.12-2.0%2.70%1,51310ARGXargenx$494.46+1.7%2.66%3,01611LEGNLegend Biotech$56.61-4.3%2.54%27,35912SYKStryker$331.67+1.3%2.51%3,88713MRKMerck & Co., Inc.$125.30-0.4%2.37%9,60014EWEdwards Lifesciences$62.37+4.5%2.31%13,00015PENPenumbra$178.41-6.1%2.20%6,18616GKOSGlaukos$119.82+1.8%2.03%8,60017TMOThermo Fisher Scientific$607.14+2.1%1.98%1,90718LFSTLifeStance Health Group$5.58+0.7%1.94%184,46119RPRXRoyalty Pharma$28.79+0.4%1.93%37,69720EXASExact Sciences$45.30-6.3%1.85%21,53021TECHBio-Techne$80.60+2.5%1.84%12,58822VEEVVeeva Systems$192.55+3.2%1.84%5,18123DXCMDexCom$64.00-40.7%1.57%7,30724INSPInspire Medical Systems$125.79-6.9%1.51%5,82425MASIMasimo$108.99-0.7%1.47%6,88826PCVXVaxcyte$84.05+0.5%1.46%9,28527HUMHumana$392.63+1.6%1.44%1,97628SRPTSarepta Therapeutics$144.24-2.2%1.43%4,93129RGENRepligen$140.79+6.4%1.36%5,62530RMDResMed$197.04-5.4%1.32%3,44431CYTKCytokinetics$59.69+2.0%1.26%11,73532XENEXenon Pharmaceuticals$43.96+0.3%1.22%15,46933Lonza Group LtdN/A1.18%1,06334PRVAPrivia Health Group$20.46+2.4%1.16%33,94635JANXJanux Therapeutics$43.99+2.9%1.14%14,04236VRTXVertex Pharmaceuticals$495.26+0.6%1.07%1,14137Sartorius Stedim Biotech SAN/A1.05%2,99638WSTWest Pharmaceutical Services$284.79+2.8%1.03%1,62039BRKRBruker$66.81+4.0%1.02%8,36340ASNDAscendis Pharma A/S$133.75-0.5%1.00%3,865Prepare for a Recession Unlike Any Other (Ad)Dave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.GET THE FREE GUIDE41AGLagilon health$6.90+2.2%0.97%82,49442PHRPhreesia$24.79+1.5%0.97%24,53443TNDMTandem Diabetes Care$40.05-1.5%0.97%11,17844Fidelity Securities Lending Cash Central FundN/A0.96%499,95045NTRANatera$102.67+0.5%0.92%4,32746ALGNAlign Technology$220.45-2.5%0.90%1,84547Fidelity Cash Central FundN/A0.85%446,63948EVHEvolent Health$23.66+6.6%0.81%21,52849TXG10x Genomics$20.22+1.5%0.76%23,24850ARWRArrowhead Pharmaceuticals$28.19-2.6%0.74%13,711 Geographic ExposureUnited States93.7%Belgium2.3%Switzerland1.3%Canada1.3%France1.0%Cayman Islands0.4%Currency ExposureUSD95.6%EUR3.3%CHF1.3%Sector ExposureHealth Care75.7%Consumer Discretionary3.1%Technology1.8%Materials1.3%Industry ExposureHealth Care Equipment & Supplies39.7%Biotechnology27.3%Health Care Providers & Services7.6%Diversified Consumer Services3.1%Software1.8%Chemicals1.3%Health Care Technology1.1%SubIndustry ExposureHealth Care Equipment25.6%Biotechnology23.4%Life Sciences Tools & Services13.0%Managed Health Care7.2%Health Care Supplies3.5%Application Software1.8%Specialty Chemicals1.3%Health Care Technology1.1%Health Care Services0.4% Related Companies and Tools Related Companies: iShares Paris-Aligned Climate MSCI World ex USA ETF Portfolio Fidelity Disruptive Communications ETF Portfolio Tema Oncology ETF Portfolio Invesco ESG NASDAQ 100 ETF Portfolio Global X Aging Population ETF Portfolio Global X Telemedicine & Digital Health ETF Portfolio Global X Data Center & Digital Infrastructure ETF Portfolio Fidelity Disruptive Finance ETF Portfolio Global X Clean Tech ETF Portfolio Global X E-Commerce ETF Portfolio This page (NASDAQ:FMED) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fidelity Disruptive Medicine ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Fidelity Disruptive Medicine ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
